Sapphire Star Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,519
Closed -$349K 107
2016
Q4
$349K Buy
+5,519
New +$349K 0.39% 43